Ligand Pharmaceuticals, Inc. Aktie - Unternehmensdaten & Kurse - US53220K2151 | goSPATZ

Ligand Pharmaceuticals, Inc.

Share · US53220K2151 (OTC)

No Price

Closing Price OTC 29.01.2026: 0,006 USD

29.01.2026 14:30

Current Prices from Ligand Pharmaceuticals, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	LGNDZ	USD	29.01.2026 14:30	0,006 USD	0,0007 USD +14,29 %

Company Profile for Ligand Pharmaceuticals, Inc. Share

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

AI Analysis of Ligand Pharmaceuticals, Inc.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Ligand Pharmaceuticals, Inc.

No AI threads available for this company yet.

Company Data

Name Ligand Pharmaceuticals, Inc.

Company Ligand Pharmaceuticals, Inc.

Website https://www.ligand.com

Primary Exchange

UTC

ISIN US53220K2151

Asset Class Share

Sector Healthcare

Industry Medical - Pharmaceuticals

CEO Todd C. Davis

Country United States of America

Currency USD

Employees 0,1 T

Address 555 Heritage Drive, Jupiter

Ticker Symbols

Name	Symbol
Over The Counter	LGNDZ

More Shares

Investors who hold Ligand Pharmaceuticals, Inc. also have the following shares in their portfolio:

CHESSCOIN Crypto

VEOLIA ENV. 25/37 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026